Holen Sie sich die Stockscreener-App
58.18
2.85%
1.61
Handel nachbörslich:
58.18
Schlusskurs vom Vortag:
$56.57
Offen:
$56.55
24-Stunden-Volumen:
898.23K
Relative Volume:
0.93
Marktkapitalisierung:
$3.55B
Einnahmen:
$249.12M
Nettoeinkommen (Verlust:
$-90.19M
KGV:
-34.22
EPS:
-1.7
Netto-Cashflow:
$-88.21M
1W Leistung:
-0.07%
1M Leistung:
+0.41%
6M Leistung:
-30.04%
1J Leistung:
-7.88%
1-Tages-Spanne:
$56.00
$60.02
1-Wochen-Bereich:
$56.00
$60.02
52-Wochen-Spanne:
$47.04
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
Firmenname
Procept Biorobotics Corp
Sektor
Branche
Telefon
(650) 232-9832
Adresse
150 BAYTECH DRIVE, SAN JOSE
Vergleichen Sie PRCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
58.18 | 3.55B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
134.11 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.63 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.81 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.28 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.02 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Eingeleitet | Jefferies | Hold |
| 2023-08-11 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-31 | Eingeleitet | William Blair | Outperform |
| 2022-10-31 | Eingeleitet | BTIG Research | Neutral |
| 2022-10-25 | Eingeleitet | Truist | Buy |
| 2022-09-02 | Eingeleitet | Wells Fargo | Overweight |
| 2022-07-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Procept Biorobotics Corp Aktie (PRCT) Neueste Nachrichten
Procept BioRobotics stock maintains buy rating at Truist on utilization trends - Investing.com
Procept BioRobotics at 2025 Truist Conference: Strategic Growth Path - Investing.com
Rhumbline Advisers Buys 3,077 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Robotics Stocks To ResearchJune 5th - MarketBeat
PROCEPT BioRobotics Corp (PRCT) Shares Up 6.15% on Jun 5 - GuruFocus
Procept Biorobotics at Jefferies Conference: Strategic Innovations in BPH Treatment - Investing.com
Procept BioRobotics at 45th Annual William Blair Growth Stock Conference: Aquablation Advances - Investing.com
PROCEPT BioRobotics Corp (PRCT) Shares Up 5.85% on Jun 3 - GuruFocus
PROCEPT BioRobotics Corp (PRCT) Stock Price Up 3.89% on May 30 - GuruFocus
PROCEPT BioRobotics Corp (PRCT) Stock Price Down 3.29% on May 29 - GuruFocus
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Shares Sold by Ameriprise Financial Inc. - Defense World
Robotics Stocks To Follow TodayMay 18th - MarketBeat
PROCEPT BioRobotics Stock Takes a Breather. Is It a Buy? - Nanalyze
Procept BioRobotics at Bank of America Conference: Strategic Growth Insights - Investing.com
Stock Performance Spotlight: Procept BioRobotics Corp (PRCT) Ends the Day at 53.11, Down by -0.23 - DWinneX
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Procept BioRobotics Corp (PRCT) expanding its growth trajectory ahead - Sete News
Ready to Jump After Recent Trade: Incyte Corp (INCY) - Sete News
Leerink Partnrs Has Negative Outlook of PRCT Q2 Earnings - Defense World
Market Insight: Procept BioRobotics Corp (PRCT)’s Notable Drop, Closing at 53.98 - DWinneX
William Blair Issues Pessimistic Forecast for PRCT Earnings - Defense World
Did Procept BioRobotics Corp (PRCT) perform well in the last session? - uspostnews.com
Mariner LLC Purchases 2,429 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
PROCEPT BioRobotics Leadership to Present at Four Premier Healthcare Investment Conferences - Stock Titan
Leerink cuts Procept BioRobotics price target to $90, keeps outperform By Investing.com - Investing.com Nigeria
Promising Potential of PROCEPT BioRobotics’ Aquablation Technology in Prostate Cancer Treatment Drives Buy Rating - TipRanks
Leerink cuts Procept BioRobotics price target to $90, keeps outperform - Investing.com
Bank of America Cuts PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $84.00 - Defense World
Procept BioRobotics Corp [PRCT] Records 50-Day SMA of $58.96 - knoxdaily.com
Procept BioRobotics price target lowered to $84 from $104 at BofA - TipRanks
Closing Figures: Procept BioRobotics Corp (PRCT)’s Negative Finish at 52.56, Down -5.64 - DWinneX
Procept BioRobotics Corp [PRCT] stock Initiated by Morgan Stanley analyst, price target now $105 - dbtnews.com
Where PROCEPT BioRobotics Stands With Analysts - Benzinga
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2025 Earnings Call Transcript - Insider Monkey
Procept BioRobotics (PRCT) Target Price Cut to $84 by BofA Analy - GuruFocus
Procept BioRobotics reports Q1 EPS (45c), consensus (49c) - TipRanks
PROCEPT BioRobotics (NASDAQ:PRCT) Sees Large Volume Increase on Earnings Beat - Defense World
PROCEPT BioRobotics Sees Strong Revenue Growth in Q1 2025 - TipRanks
Earnings call transcript: Procept Biorobotics beats Q1 2025 EPS forecast By Investing.com - Investing.com India
Procept Biorobotics Corp. Reports Strong Q1 Growth Amid Challenges - TipRanks
Procept BioRobotics sees FY25 revenue $323M, consensus $321.67M - TipRanks
Breakthrough BPH Treatment: Experts Reveal Long-Term Aquablation Results at Major Urology Conference - Stock Titan
Morgan Stanley lowers Procept BioRobotics price target, sees buying opportunity - TipRanks
Procept BioRobotics Corp’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com
PROCEPT BioRobotics (PRCT) Sees Significant Revenue Growth in Q1 2025 - GuruFocus
Procept BioRobotics Corp (NASDAQ:PRCT): It’s all about numbers this morning - uspostnews.com
Nothing is Better Than Procept BioRobotics Corp (PRCT) stock at the moment - Sete News
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates - MSN
Earnings call transcript: Procept Biorobotics beats Q1 2025 EPS forecast - Investing.com
Procept Biorobotics earnings beat by $0.04, revenue topped estimates - Investing.com
Why Procept Biorobotics Shares Are Under Pressure - TipRanks
Finanzdaten der Procept Biorobotics Corp-Aktie (PRCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Procept Biorobotics Corp-Aktie (PRCT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Desai Antal Rohit | Director |
Jun 11 '25 |
Sale |
63.38 |
25,000 |
1,584,525 |
39,363 |
| Desai Antal Rohit | Director |
Jun 12 '25 |
Sale |
61.49 |
25,000 |
1,537,256 |
14,363 |
0.54%
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):